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Abstract
Rationale Animal studies suggest that the pineal hormone
melatonin influences basal stress hormone levels and
dampens hormone reactivity to stress.
Objectives We investigated whether melatonin also has a
suppressive effect on stress-induced catecholamine and
cortisol release in humans. As stress hormones affect
memory processing, we further examined a possible
accompanying modulation of memory function.
Materials and methods Fifty healthy young men received a
single oral dose of either 3 mg melatonin (n=27) or placebo
medication (n=23). One hour later, they were exposed to a
standardized psychosocial laboratory stressor (Trier Social
Stress Test). During stress, subjects encoded objects
distributed in the test room, for which memory was
assessed a day later (“memory encoding under stress”).
Fifteen minutes following stress, memory retrieval for
words learnt the day before was tested (“memory retrieval
after stress”). Plasma epinephrine and norepinephrine
levels, salivary free cortisol levels and psychological
responses (attention, wakefulness) were repeatedly mea-
sured before and after stress exposure.
Results Melatonin specifically enhanced recognition mem-
ory accuracy of objects encoded under stress (p<0.001). In
contrast, 15 min after stress, when cortisol levels were
highest, retrieval of memories acquired the day before was
not influenced by melatonin. Moreover, melatonin did not
influence stress-induced elevation of catecholamine and
cortisol levels which in turn did not correlate with the
effects of melatonin on memory.
Conclusions The findings point to a primary action of
melatonin on central nervous stimulus processing under
conditions of stress and possibly on memory consolidation
and exclude any substantial suppressive action of the
substance on hormonal stress responses.
Keywords Melatonin .Memory . Recognition . Stress .
Cortisol . Norepinephrine . Epinephrine
Introduction
Acute stress activates the sympathetic nervous system
and the hypothalamic–pituitary–adrenal (HPA) axis,
leading to heightened levels of catecholamines (epineph-
rine and norepinephrine) and glucocorticoids (cortisol in
primates, corticosterone in rodents; Mason 1968, Kirschbaum
et al. 1993).
Besides the regulation of circadian rhythms and sleep
(Brzezinski 1997; Cajochen et al. 2003), the pineal
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hormone melatonin has been found to directly modulate
catecholamine and cortisol levels. In rodents, exogenously
administered melatonin decreases norepinephrine and epi-
nephrine levels (Girouard et al. 2003; K-Laflamme et al.
1998; Viswanathan et al. 1986; Wang et al. 1999).
Although not uniform, in young human subjects, placebo-
controlled studies revealed decreased plasma levels of
norepinephrine but not of epinephrine within 60–90 min
after oral intake of 1 or 2 mg melatonin (Arangino et al.
1999; Cagnacci et al. 1998; Nishiyama et al. 2001). In
contrast, effects of melatonin on cortisol/corticosterone
levels are less consistent. In young humans, single or
repeated administration of melatonin did not affect basal or
pharmacologically stimulated cortisol secretion (Cagnacci
et al. 1995; Forsling et al. 1999; Pawlikowski et al. 2002;
Perras et al. 2005; Seabra et al. 2000; Waldhauser et al.
1987; Wright et al. 1986), whereas in rats and primates, the
corresponding glucocorticoid measures were found to be
decreased after melatonin (Konakchieva et al. 1997, 1998;
Torres-Farfan et al. 2003). Notably, besides lowering basal
corticosterone concentrations, in rats melatonin also atten-
uated corticosterone reactivity to an acute or chronic
stressor (Konakchieva et al. 1997). Here we aimed to
examine whether melatonin likewise attenuates cortisol as
well as catecholamine reactivity to an acute stressor in
humans.
Because the stress hormones of interest here, epineph-
rine, norepinephrine and cortisol, influence encoding,
consolidation and retrieval of memories (Roozendaal et
al. 2006), a second aim of our study was to examine
whether a modulation of the stress response by mel-
atonin would be accompanied by changes in memory
processing.
In rodents and humans, increased levels of epineph-
rine and norepinephrine improve memory formation
(Cahill and Alkire 2003; McGaugh and Roozendaal
2002; O’Carroll et al. 1999; Southwick et al. 2002), while
blockade of the beta-adrenergic system inhibits memory
formation (Cahill et al. 1994; van Stegeren et al. 1998).
Furthermore, acute glucocorticoid administration or stress-
induced endogenous glucocorticoid release specifically
affects different memory phases in rodents and humans.
As such, glucocorticoids dose-dependently enhance mem-
ory encoding and consolidation (Abercrombie et al. 2003;
Beckner et al. 2006; de Kloet et al. 1999; Roozendaal
2000; Roozendaal et al. 2006) but distinctly impair
memory retrieval (Buchanan et al. 2006; de Quervain et
al. 1998, 2000; Domes et al. 2005). We expected that a
dampening effect of melatonin on the hormonal stress
response is accompanied by reduced encoding under stress
(due to suppressed catecholamine and cortisol levels) but
improved retrieval of memories (due to suppressed cortisol
levels).
Materials and methods
Participants
The study is part of a larger project investigating effects of
melatonin administration on psychobiological stress reactivity
(Wirtz et al. 2008). The study sample consisted of 50
healthy, medication-free, non-smoking men (20–35 years).
Subjects with any acute or chronic somatic or psychiatric
disorders were excluded. Additional exclusion criteria, as
obtained by subjects’ self-report, included regular strenu-
ous exercise, smoking, alcohol and illicit drug abuse, heart
disease, elevated blood sugar and diabetes, elevated
cholesterol, liver and renal diseases, chronic obstructive
pulmonary disease, allergies and atopic diathesis, rheumat-
ic diseases, current infectious diseases and insufficient
knowledge of the German language. If the personal history
was not conclusive, the subjects’ primary-care physician
was contacted for clarification. The Ethics Committee of
the State of Zürich, Switzerland formally approved the
research protocol. All participants provided written in-
formed consent before participating and received 100
Swiss francs after participation.
Design and procedure
A placebo-controlled, single-blind, between-subjects design
was used, with 27 men recruited for the melatonin group
and 23 men in the placebo group. Raw data coding and
analysis was conducted by an independent person blind to
the drug condition. Participants in both groups took part in
three experimental sessions taking place on three consec-
utive days (Fig. 1). They abstained from food and drinks
(other than water) for 2 h prior to experimental sessions and
from beverages with caffeine or alcohol and physical
activity, starting on the evening 2 days before the first
experimental session. Participants maintained a regular
sleep–wake rhythm the three nights before and during the
study, with sleep between 10–11.30 P.M. and 7–8.30 A.M.
Sessions started between 1 and 2 P.M. and, for each
participant, always at the same time of day. On day 1,
subjects were tested for normal cardiovascular functioning.
After subjects had been sitting quietly for 20 min, heart rate
and blood pressure were assessed by fully automated
plethysmography (Omron 773, Mannheim, Germany). In
the first session (day 1) subjects learnt a list of words that
was used for later testing memory retrieval under conditions
of stress during the second session (day 2). In the second
session, hormonal responses to the Trier Social Stress Test
(TSST) as well as memory under conditions of stress
(“memory retrieval after stress”) were tested after subjects
had received either placebo or melatonin (3 mg, orally,
“Melatonin Standard” purchased from PhysioLogics,
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Northglenn, CO, 80234 USA). Drugs were administered
60 min before the TSST, based on the known kinetics of
melatonin after oral intake of 1–5 mg indicating that, at this
time, blood levels of melatonin reach maximum values that
are maintained for at least 2–4 h (Dollins et al. 1994;
Waldhauser et al. 1984). The third session (day 3) served to
test memory retrieval of items (objects distributed in the test
room) that the subjects had encoded under conditions of
stress (“memory encoding under stress”) on the second
session on day 2.
Psychosocial stress procedure and hormone measurements
On the second session, 90 min after subjects had been
prepared for blood sampling by insertion of an intrave-
nous catheter and 60 min after oral drug intake, stress
was induced by the Trier Social Stress Test. We applied
the standard procedure of the TSST, which combines a
short introduction phase followed by a 5-min preparation
phase, a 5-min mock job interview and a 5-min mental
arithmetic task in front of an unknown panel of one man
and one woman. The TSST has repeatedly been found
to induce profound endocrine and cardiovascular
responses (Dickerson and Kemeny 2004; Kirschbaum et
al. 1993).
Before and after the TSST, saliva and blood were sampled
repeatedly to determine the hormonal stress response.
For assessment of free cortisol levels, saliva samples
were collected immediately before (−1 min) and immedi-
ately after the TSST procedure (+1 min) as well as 10, 20,
30, 40, 50 and 60 min after completion of the TSST using
Salivette collection devices (Sarstedt, Rommelsdorf, Ger-
many). Samples were stored at −20°C until analysis with a
commercially available competitive chemiluminescence
immunoassay (LIA; IBL, Hamburg, Germany, sensitivity
of 0.16 ng/ml). Intra- and inter-assay variability was less
than 7.7% and 11.5%, respectively.
For assessment of plasma norepinephrine, epinephrine
and melatonin levels, blood was sampled in ethylenedi-
amine tetraacetic acid-coated monovettes (Sarstedt, Num-
brecht, Germany) immediately before (−1 min) and after
the stressor (+1 min), as well as 10, 20 and 60 min after
TSST completion. Blood was immediately centrifuged for
10 min at 2,000×g at 4°C; and plasma was stored at −80°C
until analysis. Epinephrine and norepinephrine levels
were determined by means of high-performance liquid
chromatography (HPLC) and electrochemical detection
after liquid–liquid extraction (Ehrenreich et al. 1997).
Melatonin was extracted with methylene chloride and
analysed with a reversed-phase HPLC with fluorescence
detection (Vieira et al. 1992). The lower limit of detection
(LOD) for the melatonin concentration was 2.5 pg/mL.
Samples with a melatonin concentration below the LOD
were set at half the LOD (i.e. 1.25 pg/ml) following
previous recommendation for a skewed data set (Hornung
and Reed 1990). Inter- and intra-assay coefficients of
variation were <10%.
Testing of memory encoding under stress and memory
retrieval after stress
Memory encoding under stress To examine the influence of
melatonin on memory encoding under stress on day 2, 22
objects (e.g. a telephone, a glass, a bottle and a rubbish-bin)
were placed in the TSST room. All objects were put in the
subjects’ field of view. It was assured that subjects
perceived all relevant objects during the TSST by instruct-
ing them to look around for a minute and to comment on
the set-up of the room at the transition from the speech to
the mental arithmetic part of the TSST. On day 3, free recall
and recognition of the objects were tested. For recognition
memory, photos of the 22 objects were presented with 44
similar objects as distractors.
Memory retrieval after stress For assessment of the
influence of melatonin on memory retrieval under height-
ened cortisol levels, on day 1 (1 day prior to stress
exposure), subjects were instructed to memorize 30 words
Day 1 Day 2 Day 3
Encoding of Words
HR / BP measurement
Free Recall of Words
Melatonin / Placebo
TSST / Encoding of Objects
Free recall / Recognition of 
Words from Day 1
60 min
15 min Free Recall / Recognition
of Objects from Day 2
Fig. 1 Overview of the experimental sessions. Learning of words
took place on day 1. On day 2, subjects were administered melatonin
or placebo and underwent the psychosocial stress test (TSST). During
the TSST, subjects encoded memory for objects. After the TSST,
subjects retrieved the words learnt on day 1. On day 3, retrieval of
objects learnt during stress took place
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(10 positive, 10 neutral and 10 negative), which were
presented in randomized order for 5 s each (Kuhlmann et al.
2005b). Immediately following the presentation, free recall
of the words was tested. On day 2, a surprise delayed free
recall test and recognition test of the words learnt the day
before were employed 15 min after cessation of the TSST,
when cortisol levels peak. For the recognition test, 60
distractor words matched to the target words for valence
(20 positive, 20 neutral and 20 negative) were included
(Domes et al. 2004). To account for possible within- and
between-subject variance in memory, free recall performance
after stress was expressed as the percentage of words
remembered in relation to the words remembered immediately
after learning on the day before (Kuhlmann et al. 2005a, b).
Measures of recognition memory were determined
according to the two-threshold model (Snodgrass and
Corwin 1988), including hit rate (HR = proportion of old
objects classified as “old”), false alarm rate (FAR =
proportion of new objects classified as “old”), the memory
accuracy measure Pr [= HR−FAR] and the response bias
measure Br [=FAR/(1−Pr)].
Assessment of attention, mood and anxiety
Influence of melatonin on attention, concentration, wake-
fulness and state anxiety were assessed before and after the
stressor using the d2 letter cancellation test of attention
(−65 min; +35 min; Brickenkamp 1994), the wakefulness
scale of the Multidimensional Mood Questionnaire
(MDBF;−80 min, −20 min, +20 min; Steyerberg et al.
2001) and the state scale of the State-Trait-Anxiety-
Inventory (STAI; −85 min, −20 min, +5 min; Spielberger
et al. 1970). Baseline measures for attention, wakefulness
and state anxiety were obtained before melatonin or
placebo administration. All questionnaires have been
broadly used and shown satisfactory internal consistency
and validity.
Statistical analyses
SPSS (version 14.0) software packages (SPSS, Chicago, IL,
USA) was used for data analysis. Data are presented as
mean ± SEM. All tests were two-sided, and the level of
significance was set at p<0.05. Missing data were excluded
listwise.
To determine changes in hormone levels and psycho-
logical measures, two-way analyses of variance (ANOVAs)
with repeated measures were calculated with group (mela-
tonin vs. placebo) as between-subject factor and time as
within-subject factor (repeated factor: 2 for attention, 3 for
wakefulness and state anxiety, 5 for epinephrine and
norepinephrine, 8 for cortisol). To account for effects of
repeated measurements, we applied Huynh–Feldt correc-
tions for repeated measures. We present corrected p values
but provide the original degrees of freedom without
Huynh–Feldt correction. Baseline hormonal levels as well
as differences in memory performance between the two
groups were examined by one-way ANOVAs. For stress
hormones, areas under the total response curve with respect
to ground (AUCg) were calculated with the trapezoid
formula (Pruessner et al. 2003). In order to assess whether
the stress hormones modulated the influence of melatonin
on memory, respective hormone AUCg were introduced as
covariates in the ANOVA.
Results
Group characteristics and melatonin levels
Table 1 provides subjects’ characteristics for the two groups
of men treated with 3 mg melatonin (n=27) and placebo
(n=23). There were no differences in age, body mass index,
heart rate and blood pressure (all p>0.11). Also, attention
performance on the d2 test, state anxiety and wakefulness
Table 1 Group characteristics of melatonin and placebo group
Melatonin (3 mg; N=27) Placebo (N=23) p
Age (years) 24.41±0.70 25.70±0.93 0.267
Body mass index (kg/m2) 23.01±0.51 23.17±0.50 0.826
Heart rate (day 1; beats/min) 70.48±2.23 64.95±2.57 0.110
MAP (day 1; mmHg) 94.65±1.65 93.98±2.10 0.800
Attention (d2; −65 min; score) 504.85±13.41 486.39±15.49 0.370
Wakefulness (MDBF; −80 min; score] 16.08±0.54 15.22±0.55 0.274
State anxiety (STAI; −85 min; score) 36.88±1.90 35.36±1.71 0.560
Hit rate immediate recall (day 1; score) 0.62±0.03 0.63±0.02 0.730
False alarm rate immediate recall (day 1; score) 0.59±0.15 0.52±0.17 0.755
Values given are mean ± SEM
MAP mean arterial blood pressure, calculated as 2/3 diastolic blood pressure + 1/3 systolic blood pressure; hit rate proportion of old objects
classified as “old”; false alarm rate proportion of new objects classified as “old”; MDBF Multidimensional Mood Questionnaire
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before drug intake on day 2 as well as immediate free recall
of words (measured on day 1) were comparable between
groups (melatonin: hits 18.59±0.93, false alarms 0.59±0.15;
placebo: hits 19.00±0.65, false alarms 0.52±0.17; all p’s>
0.27). Measurement of melatonin in plasma samples 1 min
prior to TSST exposure (day 2) confirmed higher plasma
melatonin concentrations 60 min after substance intake in the
melatonin group (421.8±113.9 pg/ml, vs. 2.3±0.4 pg/ml in
the placebo group F(1,48)=12.00, p<0.001).
Stress hormone levels at baseline and stress responses
At baseline Resting levels of cortisol (p=0.57), norepi-
nephrine (p=0.22) and epinephrine (p=0.41) did not differ
between groups.
Stress responses Results on catecholamine stress reactivity
have been previously reported (Wirtz et al. 2008). The TSST
induced strong increases in cortisol (F(7,301)=29.1, p<
0.001), norepinephrine (F(4,176)=66.9, p<0.001) and epi-
nephrine levels (F(4,168)=16.5, p<0.001; Fig. 2). Compared
with placebo after melatonin, epinephrine levels were, on
average, slightly higher, and norephinephrine levels were, on
average, slightly lower. However, these differences did not
reach any significance. The groups did neither significantly
differ before and after stress (main effect of group) nor in
response to stress (interaction group-by-time) in cortisol (p’s>
0.47), norepinephrine (p’s>0.18), and epinephrine (p’s>0.14).
Effects of melatonin on memory encoding under stress
and memory retrieval after stress
Memory encoding under stress Recognition of objects that
were encoded during TSST performance (day 2) was
measured on day 3. Recognition testing revealed large
differences between groups (Fig. 3 summarizes results for
hit rate, false alarm rate, memory accuracy and response
bias). Subjects in the melatonin group compared to the
placebo group showed distinctly enhanced memory accuracy
(Pr; melatonin 0.32±0.02 vs. placebo 0.22±0.04, F(1,49)=
5.44, p<0.05) for objects encoded under stress exposure.
An overall higher hit rate (melatonin 0.50±0.02 vs. placebo
0.38±0.02, F(1,49)=22.15, p<0.001) contributed to this
effect. False alarm rate (p=0.58) and response bias (Br; p=
0.07) did not significantly differ between the groups. Free
recall of objects did not reveal any significant difference
between the melatonin (hits 6.52±0.35, false alarms 0.48±
0.14) and placebo (hits 6.17±0.33, false alarms 0.48±0.17)
groups (all p’s>0.48).
Memory retrieval after stress As to retrieval function under
conditions of stress, melatonin did not influence free recall
Fig. 2 a, b Values are means ± SEM. Across all subjects, the Trier
Social Stress Test (large shaded area) elicited a significant response in
stress hormone levels (a–c). The TSST combines a short introduction
phase followed by a 5-min preparation phase, a 5-min mock job
interview and a 5-min mental arithmetic task in front of an unknown
panel of one man and one woman. The melatonin and the placebo
group did not differ in hormonal reactivity to the TSST (all p’s>0.14)
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of words (15 min after stress on day 2) learnt on day 1
(main effect of treatment, p>0.49; melatonin: hits 13.00±
0.87, false alarms 1.22±0.29; placebo: hits 12.70±0.72,
false alarms 1.00±0.27). Similarly, there was no influence
of melatonin on the free recall of words depending on the
valence (positive, neutral, negative) of the words (p>0.99,
for valence by treatment interaction; positive words:
melatonin: hits 4.33±0.31; placebo: hits 4.00±0.31; neutral
words: melatonin: hits 4.63±0.42, placebo: hits 4.48±0.38;
negative words: melatonin: hits 4.04±0.38; placebo: hits
4.22±0.36). Melatonin compared to placebo also had no
influence on recognition measures of the words (melatonin:
hits 21.48±1.39, false alarms 4.04±0.61; placebo: hits
23.43±1.26, false alarms 3.61±0.54), regardless of valence
(all p’s>0.22; positive words: melatonin: hits 7.72±0.32;
placebo: hits 8.27±0.40; neutral words: melatonin: hits
8.04±0.38, placebo: hits 8.45±0.29; negative words:
melatonin: hits 7.44±0.30; placebo: hits 7.91±0.29).
Influence of stress hormones on melatonin memory effects
Since previous studies indicated strong influences of
cortisol and catecholamines on encoding and retrieval of
memories (de Quervain et al. 2000; McGaugh and
Roozendaal 2002), in supplementary analyses, we con-
trolled for the stress response of each of these hormones by
entering the respective AUCg as covariate into memory
ANOVAs. None of these analyses of covariance did reveal
any significance for any hormonal covariate (all p’s>0.25)
but confirmed the treatment effects reported above for the
original analyses.
Attention, wakefulness, mood and anxiety
Attention significantly increased from before stress
(−65 min; melatonin 504.85±13.41, placebo 486.39±
15.49) to the time after stress (+35 min; melatonin 538.93±
12.10, placebo 525.57±15.02; F(1,48)=147.8, p<0.001)
but did not differ between groups (all p’s>0.4). Wakeful-
ness significantly decreased throughout the experiment
(time effect: F(2,94)=14.36, p<0.001), with a stronger
decrease in the melatonin group (group by time effect: F
(2,94)=5.3, p<0.01; −80 min: melatonin 16.08±0.54,
placebo 15.22±0.55; −20 min: melatonin 13.26±0.70,
placebo 14.3±0.64; +20 min: melatonin 13.19±0.65, place-
bo 14.65±0.68). It is worthy to note that the decrease in
wakefulness as well as the increase in attention entered as
covariate did not significantly change the reported melatonin
effects on memory.
State anxiety significantly increased in both groups
during anticipation of the psychosocial stressor (time
effect: F(2,86)=42.38, p<0.001), but groups did not differ
in their state anxiety response to the psychosocial stressor
(p>0.69).
Discussion
This is the first study to assess whether melatonin
modulates hormonal stress reactivity in humans and
whether this modulation would be accompanied by changes
in memory processing. Oral administration of 3 mg
melatonin did not substantially alter cortisol, epinephrine
and norepinephrine responses to a psychosocial stressor.
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Fig. 3 Values are means ±
SEM. Melatonin compared to
placebo improved recognition
memory for the objects encoded
during the Trier Social Stress
Test stress. Melatonin enhanced
memory accuracy (hit rate mi-
nus false alarm rate). This effect
was due to a higher hit rate for
object recognition in the mela-
tonin group. False alarm rate
and response biases did not
differ between groups
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However, melatonin invoked distinct changes in memory
function. Going beyond previous studies examining effects
of melatonin on encoding/consolidation and retrieval
processes in combination, here we aimed at clearly
dissociating effects of melatonin on these two types of
memory processes. The central finding of our study is that
melatonin specifically improved memory for objects that
were presented together with the stressor, as indicated by
enhanced accuracy and hit rate at a recognition test for
these objects a day later. In contrast, 15 min after stress,
when cortisol levels were highly elevated, memory retrieval
of words learnt a day before remained unaffected by
melatonin. Although we cannot demonstrate a cortisol-
induced impairment of memory retrieval in both groups due
to an absent non-stressed control group (Kuhlmann et al.
2005b, Buchanan et al. 2006; Domes et al. 2004), stress
hormonal responses did not influence melatonin-modulated
effects on retrieval. The findings point to a primary action
of melatonin on central nervous stimulus processing under
conditions of stress and exclude any substantial suppressive
action of the substance on hormonal stress responses.
Notably, the melatonin-induced improvement of memory
was revealed only in a recognition test but not in free recall
testing. Recognition is a most direct test of the strength of
an association in memory, whereas free recall, in contrast to
recognition memory, is characterized by the virtual absence
of external memory cues at retrieval and thus is an indicator
of how a memory is cross-linked to other associated
memories that could facilitate its accessibility (Lockhart
2000; Tulving 1970). On this background, the selective
improvement of recognition performance strongly suggests
that melatonin enhances associative strength, i.e. the signal-
to-noise ratio at stimulus encoding under stress and
possibly during consolidation.
The present results of melatonin effects on memory are
difficult to integrate into results from the few previous
studies investigating effects of melatonin on memory. First,
most of these studies did not separately assess encoding and
retrieval functions. Second, none of these studies tested
memory function during stress, which per se affects
memory encoding and retrieval (de Quervain et al. 1998;
Elzinga et al. 2005; Kuhlmann et al. 2005b; Leeuwenberg
et al. 1992). Concurring with the present observations, in
adult male rats, melatonin facilitated social recognition
(Argyriou et al. 1998), and in humans, several studies failed
to reveal effects of melatonin on memory using free recall
procedures (Rutledge et al. 2004; Waldhauser et al. 1984;
Wesensten et al. 2005). However, Lieberman et al. (1984)
found no effect of 240 mg melatonin on both free recall as
well as recognition memory of words. In that study, both
encoding and retrieval were measured at times of enhanced
melatonin concentration, and the melatonin dose was
distinctly higher, which may account for the divergent
findings. However, even with the 3-mg dose of the present
study, plasma levels exceeding the normal physiological
range were reached, making a saturation of receptors likely.
Interestingly, in a recent study (Gorfine et al. 2007),
subjects given 2 mg melatonin before a 2-h retention interval
between encoding and retrieval showed, similarly to subjects
who napped during the retention interval, higher activation
in the left parahippocampus at successful retrieval of word
pairs. This suggests that, in addition to the effect of
encoding, melatonin can exert a sleep-like enhancing effect
on consolidation of memories (Gorfine et al. 2007).
Consistent with numerous previous studies (Deacon and
Arendt 1995; Dollins et al. 1994; Nickelsen et al. 1989;
Rutledge et al. 2004; Waldhauser et al. 1984; Wright et al.
1986), melatonin compared to placebo decreased wakeful-
ness. As this effect was not in relation to the memory
effects of melatonin, wakefulness can be ruled out as a
possible confound. Notably, the decrease in wakefulness
also was not linked to changes in measures of attention and
concentration. Performance on the d2 concentration test
was closely comparable between the two treatment groups
before and after the stressor. Indeed, the stressor caused a
distinct increase in attention and concentration in both
groups that possibly overrode any effect of melatonin in the
opposite direction. In any case, the lack of differences in
attention and concentration safely excludes that improved
memory formation for objects encoded during stress was
due to a non-specific attention function after melatonin.
Melatonin did not influence basal levels of cortisol,
epinephrine and norepinephrine, which is in accordance
with the majority of previous findings in healthy humans
(Arangino et al. 1999; Cagnacci et al. 1995, 1998; Forsling
et al. 1999; Nishiyama et al. 2001; Pawlikowski et al. 2002;
Seabra et al. 2000; Waldhauser et al. 1987; Wright et al.
1986). Furthermore, melatonin did not affect hormonal
reactivity to stress. This finding is consistent with studies
that failed to reveal dampening effects of melatonin in men
or rats on the glucocorticoid response to an emotional
stressor or hypoglycaemia-induced HPA activation within
90 min after exposure to these stimuli (Konakchieva et al.
1998; Perras et al. 2005). While we did not find changes in
basal norepinephrine levels 60 min after melatonin intake,
other investigators observed lower norepinephrine levels in
melatonin-treated young men when measured in a supine
position but not in an upright position (Arangino et al.
1999; Nishiyama et al. 2001). Indeed, a particular sensitiv-
ity of orthostatic sympathetic regulation to the effects of
melatonin is suggested as decreased norepinephrine levels
in melatonin-treated subjects normalized after standing up
for at least 15 min (Arangino et al. 1999; Nishiyama et al.
2001). Since our subjects were sitting during evaluation of
baseline conditions, differences in body position may
account for the observed discrepancy.
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The neurophysiological mechanisms mediating the en-
hancing effect of melatonin on memory formation are
elusive. Since no melatonin-induced changes in stress
hormone levels were observed, our findings are unlikely
to be mediated by cortisol, epinephrine or norepinephrine.
We offer two explanations potentially underlying the effect
of melatonin on memory encoding. First, melatonin binding
sites exist in various brain structures involved in memory
function such as the hippocampus and prefrontal cortex
(Brzezinski 1997; Ekmekcioglu 2006; Mazzucchelli et al.
1996; Savaskan et al. 2001, 2005). Under non-stress
conditions, melatonin reduced rather than improved induction
of long-term potentiation (LTP) in hippocampal slices from
mice, i.e. a synaptic plastic process believed to underlie the
encoding of novels stimuli (Ozcan et al. 2006; Wang et al.
2005). Moreover, a recent study in zebrafish describes a
suppressive effect of administration of a very high melatonin
dose on nighttime memory formation under non-stress
conditions (Rawashdeh et al. 2007). However, it is unknown
whether these animal findings apply to daytime memory
formation under resting conditions in humans. It is presently
not known but conceivable that stress conditions as investi-
gated in the present study promote the release of neuro-
modulators (e.g. norepinephrine) that are able to shift the effect
of melatonin on LTP induction into an opposite direction.
Second, considering that melatonin is a potent sleep-
inducing factor (Wright et al. 1986) and sleep is known to
enhance consolidation of hippocampus-dependent memo-
ries (Jern et al. 1991; Rasch et al. 2007), it is possible that
‘sleep-like’ melatonin effects on consolidation in the
aftermath of encoding added to its effects on encoding.
Indeed, since melatonin in the used dose is known to
degrade to baseline levels in 4 to 8 h after oral ingestion
(Brzezinski 1997), it is likely that melatonin also influenced
early processes of memory consolidation in our study.
However, this rationale implies a similar effect of melatonin
also under basal resting conditions not investigated here,
which limits the interpretation of our data.
In summary, our data indicate that melatonin rather than
dampening hormonal responses to a social stressor exerts a
genuinely central nervous effect by enhancing encoding of
objects under stress and possibly memory consolidation.
Strength and specificity of this effect call for investigating
whether this effect emerges selectively during stress
conditions or likewise during rest.
References
Abercrombie HC, Kalin NH, Thurow ME, Rosenkranz MA, Davidson
RJ (2003) Cortisol variation in humans affects memory for
emotionally laden and neutral information. Behav Neurosci
117:505–516
Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G, Volpe
A, Melis GB (1999) Effects of melatonin on vascular reactivity,
catecholamine levels, and blood pressure in healthy men. Am J
Cardiol 83:1417–1419
Argyriou A, Prast H, Philippu A (1998) Melatonin facilitates short-
term memory. Eur J Pharmacol 349:159–162
Beckner VE, Tucker DM, Delville Y, Mohr DC (2006) Stress
facilitates consolidation of verbal memory for a film but does
not affect retrieval. Behav Neurosci 120:518–527
Brickenkamp R (1994) d2 Aufmerksamkeits-Belastungs-Test. Hog-
refe, Göttingen
Brzezinski A (1997) Melatonin in humans. N Engl J Med 336:186–
195
Buchanan TW, Tranel D, Adolphs R (2006) Impaired memory
retrieval correlates with individual differences in cortisol
response but not autonomic response. Learn Mem 13:382–387
Cagnacci A, Soldani R, Yen SS (1995)Melatonin enhances cortisol levels
in aged but not young women. Eur J Endocrinol 133:691–695
Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB (1998)
Influences of melatonin administration on the circulation of
women. Am J Physiol 274:R335–R338
Cahill L, Alkire MT (2003) Epinephrine enhancement of human
memory consolidation: interaction with arousal at encoding.
Neurobiol Learn Mem 79:194–198
Cahill L, Prins B, Weber M, McGaugh JL (1994) Beta-adrenergic
activation and memory for emotional events. Nature 371:702–704
Cajochen C, Krauchi K, Wirz-Justice A (2003) Role of melatonin in
the regulation of human circadian rhythms and sleep. J Neuro-
endocrinol 15:432–437
de Kloet ER, Oitzl MS, Joels M (1999) Stress and cognition: are
corticosteroids good or bad guys? Trends Neurosci 22:422–426
de Quervain DJ, Roozendaal B, McGaugh JL (1998) Stress and
glucocorticoids impair retrieval of long-term spatial memory.
Nature 394:787–790
de Quervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C
(2000) Acute cortisone administration impairs retrieval of long-
term declarative memory in humans. Nat Neurosci 3:313–314
Deacon S, Arendt J (1995) Melatonin-induced temperature suppres-
sion and its acute phase-shifting effects correlate in a dose-
dependent manner in humans. Brain Res 688:77–85
Dickerson SS, Kemeny ME (2004) Acute stressors and cortisol
responses: a theoretical integration and synthesis of laboratory
research. Psychol Bull 130:355–391
Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH (1994)
Effect of inducing nocturnal serum melatonin concentrations in
daytime on sleep, mood, body temperature, and performance.
Proc Natl Acad Sci USA 91:1824–1828
Domes G, Heinrichs M, Rimmele U, Reichwald U, Hautzinger M (2004)
Acute stress impairs recognition for positive words–association with
stress-induced cortisol secretion. Stress 7:173–181
Domes G, Rothfischer J, Reichwald U, Hautzinger M (2005) Inverted-
U function between salivary cortisol and retrieval of verbal
memory after hydrocortisone treatment. Behav Neurosci
119:512–517
Ehrenreich H, Schuck J, Stender N, Pilz J, Gefeller O, Schilling L,
Poser W, Kaw S (1997) Endocrine and hemodynamic effects of
stress versus systemic CRF in alcoholics during early and
medium term abstinence. Alcohol Clin Exp Res 21:1285–1293
Ekmekcioglu C (2006) Melatonin receptors in humans: biological role
and clinical relevance. Biomed Pharmacother 60:97–108
Elzinga BM, Bakker A, Bremner JD (2005) Stress-induced cortisol
elevations are associated with impaired delayed, but not
immediate recall. Psychiatry Res 134:211–223
Forsling ML, Wheeler MJ, Williams AJ (1999) The effect of
melatonin administration on pituitary hormone secretion in
man. Clin Endocrinol (Oxf) 51:637–642
670 Psychopharmacology (2009) 202:663–672
Girouard H, Chulak C, LeJossec M, Lamontagne D, de Champlain J
(2003) Chronic antioxidant treatment improves sympathetic
functions and beta-adrenergic pathway in the spontaneously
hypertensive rats. J Hypertens 21:179–188
Gorfine T, Yeshurun Y, Zisapel N (2007) Nap and melatonin-induced
changes in hippocampal activation and their role in verbal
memory consolidation. J Pineal Res 43:336–342
Hornung R, Reed L (1990) Estimation of average concentration in the
presence of nondectable values. Appl Occup Environ Hyg 5:46–51
Jern C, Manhem K, Eriksson E, Tengborn L, Risberg B, Jern S (1991)
Hemostatic responses to mental stress during the menstrual cycle.
Thromb Haemost 66:614–618
K-Laflamme A, Wu L, Foucart S, de Champlain J (1998) Impaired
basal sympathetic tone and alpha1-adrenergic responsiveness in
association with the hypotensive effect of melatonin in sponta-
neously hypertensive rats. Am J Hypertens 11:219–229
Kirschbaum C, Pirke KM, Hellhammer DH (1993) The ‘Trier Social
Stress Test’–a tool for investigating psychobiological stress
responses in a laboratory setting. Neuropsychobiology 28:76–81
Konakchieva R, Mitev Y, Almeida OF, Patchev VK (1997) Chronic
melatonin treatment and the hypothalamo-pituitary-adrenal axis
in the rat: attenuation of the secretory response to stress and
effects on hypothalamic neuropeptide content and release. Biol
Cell 89:587–596
Konakchieva R, Mitev Y, Almeida OF, Patchev VK (1998) Chronic
melatonin treatment counteracts glucocorticoid-induced dysregu-
lation of the hypothalamic-pituitary-adrenal axis in the rat.
Neuroendocrinology 67:171–180
Kuhlmann S, Kirschbaum C, Wolf OT (2005a) Effects of oral cortisol
treatment in healthy young women on memory retrieval of
negative and neutral words. Neurobiol Learn Mem 83:158–162
Kuhlmann S, Piel M, Wolf OT (2005b) Impaired memory retrieval
after psychosocial stress in healthy young men. J Neurosci
25:2977–2982
Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T,
Jeunhomme TM, Ahern TJ, Buurman WA (1992) E-selectin and
intercellular adhesion molecule-1 are released by activated
human endothelial cells in vitro. Immunology 77:543–549
Lieberman HR, Waldhauser F, Garfield G, Lynch HJ, Wurtman RJ
(1984) Effects of melatonin on human mood and performance.
Brain Res 323(2):201–207, Dec 10
Lockhart RS (2000) Methods of memory research. Oxford Handbook
of Memory. In: Tulving E, Craik FIM (eds) Oxford University
Press, 45–57
Mason JW (1968) A review of psychoendocrine research on the
sympathetic-adrenal medullary system. Psychosom Med 30,
Suppl:631–653
Mazzucchelli C, Pannacci M, Nonno R, Lucini V, Fraschini F,
Stankov BM (1996) The melatonin receptor in the human brain:
cloning experiments and distribution studies. Brain Res Mol
Brain Res 39:117–126
McGaugh JL, Roozendaal B (2002) Role of adrenal stress hormones
in forming lasting memories in the brain. Curr Opin Neurobiol
12:205–210
Nickelsen T, Demisch L, Demisch K, Radermacher B, Schoffling K
(1989) Influence of subchronic intake of melatonin at various
times of the day on fatigue and hormonal levels: a placebo-
controlled, double-blind trial. J Pineal Res 6:325–334
Nishiyama K, Yasue H, Moriyama Y, Tsunoda R, Ogawa H,
Yoshimura M, Kugiyama K (2001) Acute effects of melatonin
administration on cardiovascular autonomic regulation in healthy
men. Am Heart J 141:E9
O’Carroll RE, Drysdale E, Cahill L, Shajahan P, Ebmeier KP (1999)
Stimulation of the noradrenergic system enhances and blockade
reduces memory for emotional material in man. Psychol Med
29:1083–1088
Ozcan M, Yilmaz B, Carpenter DO (2006) Effects of melatonin on
synaptic transmission and long-term potentiation in two areas of
mouse hippocampus. Brain Res 1111:90–94
Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M (2002)
Effects of six months melatonin treatment on sleep quality and
serum concentrations of estradiol, cortisol, dehydroepiandroster-
one sulfate, and somatomedin C in elderly women. Neuro
Endocrinol Lett 23(Suppl 1):17–19
Perras B, Ozcan S, Fehm HL, Born J (2005) Melatonin does not
inhibit hypothalamic-pituitary-adrenal activity in waking young
men. J Neuroendocrinol 17:811–816
Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH
(2003) Two formulas for computation of the area under the
curve represent measures of total hormone concentration versus
time-dependent change. Psychoneuroendocrinology 28:916–931
Rasch B, Buchel C, Gais S, Born J (2007) Odor cues during slow-
wave sleep prompt declarative memory consolidation. Science
315:1426–1429
Rawashdeh O, de Bprsetti NH, Roman G, Cahill GM (2007)
Melatonin suppresses nighttime memory formation in zebrafish.
Science 318(5853):1144–1146
Roozendaal B (2000) 1999 Curt P. Richter award. Glucocorticoids and
the regulation of memory consolidation. Psychoneuroendocrinol-
ogy 25:213–238
Roozendaal B, Okuda S, de Quervain DJ, McGaugh JL (2006)
Glucocorticoids interact with emotion-induced noradrenergic
activation in influencing different memory functions. Neurosci-
ence 138:901–910
Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ,
Mankad S, Rogers WJ, Bairey Merz CN, Sopko G, Cornell CE,
Sharaf B, Matthews KA (2004) Social networks are associated
with lower mortality rates among women with suspected
coronary disease: the National Heart, Lung, and Blood Insti-
tute-Sponsored Women's Ischemia Syndrome Evaluation study.
Psychosom Med 66:882–888
Savaskan E, Olivieri G, Brydon L, Jockers R, Krauchi K, Wirz-Justice
A, Muller-Spahn F (2001) Cerebrovascular melatonin MT1-
receptor alterations in patients with Alzheimer’s disease. Neuro-
sci Lett 308:9–12
Savaskan E, Ayoub MA, Ravid R, Angeloni D, Fraschini F, Meier F,
Eckert A, Muller-Spahn F, Jockers R (2005) Reduced hippocam-
pal MT2 melatonin receptor expression in Alzheimer’s disease. J
Pineal Res 38:10–16
Seabra ML, Bignotto M, Pinto LR Jr, Tufik S (2000) Randomized,
double-blind clinical trial, controlled with placebo, of the toxicology
of chronic melatonin treatment. J Pineal Res 29:193–200
Snodgrass JG, Corwin J (1988) Pragmatics of measuring recognition
memory: applications to dementia and amnesia. J Exp Psychol
Gen 117:34–50
Southwick SM, Davis M, Horner B, Cahill L, Morgan CA 3rd, Gold
PE, Bremner JD, Charney DC (2002) Relationship of enhanced
norepinephrine activity during memory consolidation to en-
hanced long-term memory in humans. Am J Psychiatry
159:1420–1422
Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the
state-trait anxiety inventory. Consulting Psychologists Press,
Palo Alto
Steyerberg EW, Eijkemans MJC, Harrell FE, Habbema JDF (2001)
Prognostic modeling with logistic regression analysis: In search
of a sensible strategy in small data sets.. Medical Decision
Making 21:45–56
Torres-Farfan C, Richter HG, Rojas-Garcia P, Vergara M, Forcelledo
ML, Valladares LE, Torrealba F, Valenzuela GJ, Seron-Ferre M
(2003) mt1 Melatonin receptor in the primate adrenal gland:
inhibition of adrenocorticotropin-stimulated cortisol production
by melatonin. J Clin Endocrinol Metab 88:450–458
Psychopharmacology (2009) 202:663–672 671
Tulving E (1970) Memory and verbal learning. Annu Rev Psychol
21:437–484
van Stegeren AH, Everaerd W, Cahill L, McGaugh JL, Gooren LJ
(1998) Memory for emotional events: differential effects of
centrally versus peripherally acting beta-blocking agents. Psy-
chopharmacology (Berl) 138:305–310
Vieira R, Miguez J, Lema M, Aldegunde M (1992) Pineal and
plasma melatonin as determined by high-performance liquid
chromatography with electrochemical detection. Anal Biochem
205:300–305
Viswanathan M, Hissa R, George JC (1986) Suppression of
sympathetic nervous system by short photoperiod and melatonin
in the Syrian hamster. Life Sci 38:73–79
Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ,
Wurtman RJ (1984) Bioavailability of oral melatonin in humans.
Neuroendocrinology 39:307–313
Waldhauser F, Lieberman HR, Lynch HJ, Waldhauser M, Herkner
K, Frisch H, Vierhapper H, Waldhausl W, Schemper M,
Wurtman RJ et al (1987) A pharmacological dose of melatonin
increases PRL levels in males without altering those of GH,
LH, FSH, TSH, testosterone or cortisol. Neuroendocrinology
46:125–130
Wang M, Yokotani K, Nakamura K, Murakami Y, Okada S, Osumi Y
(1999) Melatonin inhibits the central sympatho-adrenomedullary
outflow in rats. Jpn J Pharmacol 81:29–33
Wang LM, Suthana NA, Chaudhury D, Weaver DR, Colwell CS
(2005) Melatonin inhibits hippocampal long-term potentiation.
Eur J Neurosci 22:2231–2237
Wesensten NJ, Balkin TJ, Reichardt RM, Kautz MA, Saviolakis GA,
Belenky G (2005) Daytime sleep and performance following a
zolpidem and melatonin cocktail. Sleep 28:93–103
Wirtz PH, Bartschi C, Spillmann M, Ehlert U, von Kanel R (2008)
Effect of oral melatonin on the procoagulant response to acute
psychosocial stress in healthy men: a randomized placebo-
controlled study. J Pineal Res 44:358–365
Wright J, Aldhous M, Franey C, English J, Arendt J (1986) The
effects of exogenous melatonin on endocrine function in man.
Clin Endocrinol (Oxf) 24:375–382
672 Psychopharmacology (2009) 202:663–672
